Actively Recruiting
Biobank on Prematurity, Preeclampsia and Other Pregnancy Complications
Led by CHU de Quebec-Universite Laval · Updated on 2022-03-16
7845
Participants Needed
1
Research Sites
678 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Biobank includes data and biological specimens of women from three original studies: 1) First-trimester Prediction of Preeclampsia (PREDICTION Study, NCT02189148), 2) Pre-Eclampsia And growth Retardation, an evaluative Longitudinal study (PEARL Study, NCT02379832), 3) Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial (NCT02280031) and 4)PREDICTION2: Prediction of Preeclampsia and other Pregnancy Complications Following Combined Iterative Screening.
CONDITIONS
Official Title
Biobank on Prematurity, Preeclampsia and Other Pregnancy Complications
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Inclusion criteria vary depending on each specific original study
You will not qualify if you...
- Pregnant women younger than 18 years old at recruitment
- No fetal heartbeat detected at recruitment
- Women unable to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU de Quebec
Québec, Canada, G1V 4G2
Actively Recruiting
Research Team
E
Emmanuel Bujold, MD, MSc
CONTACT
S
Sylvie Tapp, MSc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
5
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here